List of Cv Therapeutics patents

Patents where

Current Assignee

Name

‌

Cv Therapeutics

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7160592 Polymer coating for medical devices	Patent 7160592 was granted and assigned to Cv Therapeutics on January, 2007 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7160592	January 9, 2007
‌ US Patent 7419709 Polymer coating for medical devices	Patent 7419709 was granted and assigned to Cv Therapeutics on September, 2008 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7419709	September 2, 2008
‌ US Patent 6900219 ABCA-1 elevating compounds	Patent 6900219 was granted and assigned to Cv Therapeutics on May, 2005 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	6900219	May 31, 2005
‌ US Patent 7432276 ABCA1 elevating compounds	Patent 7432276 was granted and assigned to Cv Therapeutics on October, 2008 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7432276	October 7, 2008
‌ US Patent 7423045 ABCA1 elevating compounds	Patent 7423045 was granted and assigned to Cv Therapeutics on September, 2008 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7423045	September 9, 2008
‌ US Patent 7300923 Partial and full agonists of A1 adenosine receptors	Patent 7300923 was granted and assigned to Cv Therapeutics on November, 2007 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7300923	November 27, 2007
‌ US Patent 7488720 A	Patent 7488720 was granted and assigned to Cv Therapeutics on February, 2009 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7488720	February 10, 2009
‌ US Patent 7553823 C-pyrazole A2A receptor agonists	Patent 7553823 was granted and assigned to Cv Therapeutics on June, 2009 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7553823	June 30, 2009
‌ US Patent 7109180 C-pyrazole A	Patent 7109180 was granted and assigned to Cv Therapeutics on September, 2006 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7109180	September 19, 2006
‌ US Patent 7157440 Partial and full agonists of A1 adenosine receptors	Patent 7157440 was granted and assigned to Cv Therapeutics on January, 2007 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7157440	January 2, 2007
‌ US Patent 7262176 Adenosine A	Patent 7262176 was granted and assigned to Cv Therapeutics on August, 2007 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7262176	August 28, 2007
‌ US Patent 7271157 A	Patent 7271157 was granted and assigned to Cv Therapeutics on September, 2007 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7271157	September 18, 2007
‌ US Patent 7696181 Partial and full agonists of A	Patent 7696181 was granted and assigned to Cv Therapeutics on April, 2010 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7696181	April 13, 2010
‌ US Patent 7238700 A	Patent 7238700 was granted and assigned to Cv Therapeutics on July, 2007 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7238700	July 3, 2007
‌ US Patent 7449473 Substituted pyrrolo[3,2-d]pyrimidin-2,4-diones as A	Patent 7449473 was granted and assigned to Cv Therapeutics on November, 2008 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7449473	November 11, 2008
‌ US Patent 7304070 A	Patent 7304070 was granted and assigned to Cv Therapeutics on December, 2007 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7304070	December 4, 2007
‌ US Patent 7452889 Substituted heterocyclic compounds	Patent 7452889 was granted and assigned to Cv Therapeutics on November, 2008 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7452889	November 18, 2008
‌ US Patent 7144872 N-pyrazole A	Patent 7144872 was granted and assigned to Cv Therapeutics on December, 2006 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7144872	December 5, 2006
‌ US Patent 7115610 Substituted heterocyclic compounds	Patent 7115610 was granted and assigned to Cv Therapeutics on October, 2006 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7115610	October 3, 2006
‌ US Patent 7517888 A	Patent 7517888 was granted and assigned to Cv Therapeutics on April, 2009 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7517888	April 14, 2009
‌ US Patent 7208496 Substituted heterocyclic compounds	Patent 7208496 was granted and assigned to Cv Therapeutics on April, 2007 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7208496	April 24, 2007
‌ US Patent 7205303 Substituted heterocyclic compounds	Patent 7205303 was granted and assigned to Cv Therapeutics on April, 2007 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7205303	April 17, 2007
‌ US Patent 7407960 Substituted heterocyclic compounds	Patent 7407960 was granted and assigned to Cv Therapeutics on August, 2008 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7407960	August 5, 2008
‌ US Patent 7125876 Substituted heterocyclic compounds	Patent 7125876 was granted and assigned to Cv Therapeutics on October, 2006 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7125876	October 24, 2006
‌ US Patent 7183264 N-pyrazole A2A receptor agonists	Patent 7183264 was granted and assigned to Cv Therapeutics on February, 2007 by the United States Patent and Trademark Office.	‌ Cv Therapeutics	United States Patent and Trademark Office	7183264	February 27, 2007

Results per page:

56 results

0 selected

56 results

0 selected